Regulatory flexibility can make continuous improvement possible.
Jim Precup
Advertisement
Jim Precup is a research scientist in manufacturing, science and technology at Eli Lilly and Company
Articles by Jim Precup
Second in a three-part series that discusses the complexities of QbD implementation in biotech development.
First in a three-part series that discusses the complexities of QbD implementation in biotech product development.
Advertisement
Latest Updated Articles
Quality by Design for Biotechnology Products—Part 3Published: January 1st 2010 | Updated:
Quality by Design for Biotechnology Products—Part 2Published: December 1st 2009 | Updated:
Quality by Design for Biotechnology Products—Part 1Published: November 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
From Parm to Pharm: Avantor, p-Chip Bring COI Compliance to Clinical Consumables
2
Ask the Expert: Commenting on Draft Regulations
3
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
4
Challenges, Innovations, and Future Outlook of Biologics Formulations
5
